MCO vs XERS · P/E 33, rev $4.26B vs rev $175.2M
Moodys Corporation (MCO) versus Xeris Pharmaceuticals Inc (XERS) — a side-by-side from cached financials, not a winner call.
Moodys Corporation (MCO) is a financial data & stock exchanges company listed on NYSE.
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
Latest reported MCO revenue for 2026-06-30 was $4.26B. Net income was $1.54B. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
Latest reported XERS revenue for 2026-06-30 was $175.2M. Net income was -$28.9M. XERS currently screens at market cap $760.7M.
MCO currently screens at market cap $79.69B and trailing P/E 32.7. XERS currently screens at market cap $760.7M.
Not investment advice. Open the MCO and XERS stock pages for the full models.
Not investment advice.